117 related articles for article (PubMed ID: 12132779)
41. Risk factors for HPV detection in archival Pap smears. A population-based study from Greenland and Denmark.
Svare EI; Kjaer SK; Smits HL; Poll P; Tjong-A-Hung SP; ter Schegget J
Eur J Cancer; 1998 Jul; 34(8):1230-4. PubMed ID: 9849485
[TBL] [Abstract][Full Text] [Related]
42. Comparison of detection of human papillomavirus 16 DNA in cervical carcinoma tissues by Southern blot hybridisation and nested polymerase chain reaction.
Chang DY; Hsieh CY; Chen RJ; Lee SC; Huang SC
J Med Microbiol; 1995 Dec; 43(6):430-5. PubMed ID: 7473676
[TBL] [Abstract][Full Text] [Related]
43. HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
Stoler MH
J Histochem Cytochem; 2001 Sep; 49(9):1197-8. PubMed ID: 11511693
[TBL] [Abstract][Full Text] [Related]
44. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
46. Clinical application of HPV typing in cervical cancer.
Namkoong SE
Int J Gynaecol Obstet; 1995 Jul; 49 Suppl():S59-67. PubMed ID: 7589742
[TBL] [Abstract][Full Text] [Related]
47. Screening of premalignant cervical lesions for HPV 16 DNA by sandwich and in situ hybridization techniques.
Parkkinen S; Syrjänen S; Syrjänen K; Yliskoski M; Tenhunen J; Mäntyjärvi R; Ranki M
Gynecol Oncol; 1988 Jun; 30(2):251-64. PubMed ID: 2836276
[TBL] [Abstract][Full Text] [Related]
48. Detection and typing of human papillomavirus in biopsy and cytological specimens by polymerase chain reaction and restriction enzyme analysis: a method suitable for semiautomation.
Adams V; Moll C; Schmid M; Rodrigues C; Moos R; Briner J
J Med Virol; 1996 Feb; 48(2):161-70. PubMed ID: 8835350
[TBL] [Abstract][Full Text] [Related]
49. Sensitivity of HPV tests on stained vs. unstained cervical smears.
de Lang A; Wilander E
Acta Cytol; 2005; 49(6):595-9. PubMed ID: 16450897
[TBL] [Abstract][Full Text] [Related]
50. [Genotyping of human papillomavirus genotyes in cervical scrapes by line probe assay].
Wang J; Bakkers J; Melchers WJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):9-12. PubMed ID: 12759942
[TBL] [Abstract][Full Text] [Related]
51. Comparison of HPV detection in parallel biopsies and cervical scrapes by PCR.
Ask E; Jenkins A; Kaern J; Trope C; Kristiansen BE
APMIS; 1992 Aug; 100(8):752-6. PubMed ID: 1325806
[TBL] [Abstract][Full Text] [Related]
52. Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention.
Surriabre P; Torrico A; Vargas T; Ugarte F; Rodriguez P; Fontaine V
BMC Infect Dis; 2019 Oct; 19(1):842. PubMed ID: 31615443
[TBL] [Abstract][Full Text] [Related]
53. Screening for cervical cancer.
Wright TC; Goldie SJ; Cain JM; Howett MK
Science; 2000 Dec; 290(5497):1651. PubMed ID: 11186376
[No Abstract] [Full Text] [Related]
54. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.
Walboomers JM; de Roda Husman AM; Snijders PJ; Stel HV; Risse EK; Helmerhorst TJ; Voorhorst FJ; Meijer CJ
J Clin Pathol; 1995 Aug; 48(8):728-32. PubMed ID: 7560199
[TBL] [Abstract][Full Text] [Related]
55. High sensitivity of PCR in situ hybridization for the detection of human papillomavirus infection in uterine cervical neoplasias.
Xiao Y; Sato S; Oguchi T; Kudo K; Yokoyama Y; Saito Y
Gynecol Oncol; 2001 Aug; 82(2):350-4. PubMed ID: 11531292
[TBL] [Abstract][Full Text] [Related]
56. [Medicine and money: detection of HPV DNA--what's the impediment?].
Miseta A
Orv Hetil; 2003 Dec; 144(52):2589-90. PubMed ID: 15005070
[No Abstract] [Full Text] [Related]
57. A non-radioactive PCR enzyme-immunoassay enables a rapid identification of HPV 16 and 18 in cervical scrapes after GP5+/6+ PCR.
Jacobs MV; van den Brule AJ; Snijders PJ; Helmerhorst TJ; Meijer CJ; Walboomers JM
J Med Virol; 1996 Jul; 49(3):223-9. PubMed ID: 8818969
[TBL] [Abstract][Full Text] [Related]
58. Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness.
van Ballegooijen M; van den Akker-van Marle ME; Warmerdam PG; Meijer CJ; Walboomers JM; Habbema JD
Br J Cancer; 1997; 76(5):651-7. PubMed ID: 9303366
[TBL] [Abstract][Full Text] [Related]
59. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract][Full Text] [Related]
60. Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison.
Jacobs MV; Snijders PJ; Voorhorst FJ; Dillner J; Forslund O; Johansson B; von Knebel Doeberitz M; Meijer CJ; Meyer T; Nindl I; Pfister H; Stockfleth E; Strand A; Wadell G; Walboomers JM
J Clin Pathol; 1999 Jul; 52(7):498-503. PubMed ID: 10605401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
